RT @temkins: Even routine CA-125s and CT scans have not been shown to improve survival from ovarian cancer (and may increase patients’ anxi…
RT @temkins: Even routine CA-125s and CT scans have not been shown to improve survival from ovarian cancer (and may increase patients’ anxi…
RT @temkins: Even routine CA-125s and CT scans have not been shown to improve survival from ovarian cancer (and may increase patients’ anxi…
Even routine CA-125s and CT scans have not been shown to improve survival from ovarian cancer (and may increase patients’ anxiety) they are commonly ordered. In the US this costs us $1,999,029/yr for CA-125 tests and $16,194,647/yr with CT scans added htt
RT @oncology_bg: Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence.…
RT @oncology_bg: Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence.…
RT @oncology_bg: Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence.…
RT @oncology_bg: Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence.…
RT @Maherjane: Exactly my experience - always “something wrong with trial” ,or “changed context “etc it makes one wary of the 10 yrs work…
And THERE YOU HAVE IT chaps ! What is the answer ? https://t.co/5eMtleb0Cz
Exactly my experience - always “something wrong with trial” ,or “changed context “etc it makes one wary of the 10 yrs work needed https://t.co/5eMtleb0Cz
RT @oncology_bg: Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence.…
Oh, we usually don't if the RCT results show "less is more" because our bias to do something trumps our trust of evidence. https://t.co/RuPPyQp6fE https://t.co/jd9bj4vg3d
RT @VinayPrasad82: Not every example of overuse is trade-offs. The use of CA125 monitoring after CR in Ovarian Ca is proven in RCT to lowe…
RT @jan_verbakel: No benefit of CA125 and CT scan surveillance testing in patients with ovarian cancer #LessIsMore https://t.co/nRzI8bhsSI
This is interesting because I see this as widespread practice. https://t.co/BorCLllnj3
No benefit of CA125 and CT scan surveillance testing in patients with ovarian cancer #LessIsMore https://t.co/nRzI8bhsSI
RT @oncology_bg: Exactly. For those interventions we don’t have data, no arguments. But there are many interventions that we already know a…
RT @oncology_bg: Exactly. For those interventions we don’t have data, no arguments. But there are many interventions that we already know a…
RT @oncology_bg: Exactly. For those interventions we don’t have data, no arguments. But there are many interventions that we already know a…
Exactly. For those interventions we don’t have data, no arguments. But there are many interventions that we already know are unnecessary and yet keep prescribing; there lies the problem. https://t.co/6RDFUkBssc
RT @oncology_bg: Let's conduct a study similar to this one https://t.co/4fLOhXm0hm for CT scan in #NSCLC after 5 years. Anybody interested…
Let's conduct a study similar to this one https://t.co/4fLOhXm0hm for CT scan in #NSCLC after 5 years. Anybody interested? https://t.co/975fpDGzFs
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
RT @LainezNuria: Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer https://t.co/zTSI9Ct1Ne
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer https://t.co/zTSI9Ct1Ne
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JackWestMD: Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM…
Data show no benefit to CA-125 surveillance, but we practice based on what we want to do, not what evidence shows. #GynCSM https://t.co/BBI4DLFDbB
RT @temkins: Surveillance in #ovariancancer patients. #CA125 and #imaging and #overtreatment. #leadtimebias. #qualityoflife #gyncsm https:/…
RT @DrMarkham: From @JAMAOnc, new study on use of CA 125 & CT for surveillance of ovarian cancer: https://t.co/9sZD3PIuF1 #gyncsm
RT @temkins: Surveillance in #ovariancancer patients. #CA125 and #imaging and #overtreatment. #leadtimebias. #qualityoflife #gyncsm https:/…
RT @DrMarkham: From @JAMAOnc, new study on use of CA 125 & CT for surveillance of ovarian cancer: https://t.co/9sZD3PIuF1 #gyncsm
Back to the old story: Routine use of CA-125 in ovarian cancer DECREASE QUALITY OF LIFE AND DOES NOT IMPROVE OS https://t.co/HZdAukbI6j
Surveillance in #ovariancancer patients. #CA125 and #imaging and #overtreatment. #leadtimebias. #qualityoflife #gyncsm https://t.co/VN1J0I4kqH
RT @DrMarkham: From @JAMAOnc, new study on use of CA 125 & CT for surveillance of ovarian cancer: https://t.co/9sZD3PIuF1 #gyncsm
From @JAMAOnc, new study on use of CA 125 & CT for surveillance of ovarian cancer: https://t.co/9sZD3PIuF1 #gyncsm
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @Vilavaite: CA-125 tests and CT scans are still routinely used for surveillance testing in ovarian cancer without proven benefit https:/…
CA-125 tests and CT scans are still routinely used for surveillance testing in ovarian cancer without proven benefit https://t.co/fXwimSZ5MM
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
The fatal attraction of testing: https://t.co/S9R1rolxM8
RT @JAMAOnc: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zwsrm1ODfg
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/zMmGs5T8xb https://t.co/Em0MvXXlGO
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer #overtreatment https://t.co/DtpQVxPw5j
卵巣がん経過観察にCA-125およびCT検査は有益性の証明なく汎用 https://t.co/d7sfrWjCtr JAMA Oncology https://t.co/Pzruj1RxnN
RT @JuanGrvas: CA-125 tests and CT scans are still routinely used for surveillance testing in ovarian cancer without proven benefit https:/…
Se utiliza en el seguimiento del cáncer de ovario el CA-125 y la TAC, que disminuyen calidad de vida sin añadir idem https://t.co/unu8zUoVWR
CA-125 tests and CT scans are still routinely used for surveillance testing in ovarian cancer without proven benefit https://t.co/unu8zUoVWR
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @EvaMLuo: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/p5wLHRtRkD #costeffectiveness #obgyn
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer https://t.co/p5wLHRtRkD #costeffectiveness #obgyn
Dilema de 'Fatal Attraction' sobre un test de cancer ovárico https://t.co/9WLVVoWtAR… vía @medscape https://t.co/48eissgm1w @JAMA_current
RT @JuanGrvas: Surveillance in Ovarian Cancer? Please, do not use CA-125 Tests and Computed Tomographic Scans @LessIsMoreMed https://t.co/…
Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer - overused/underevidenced - in @JAMAOnc https://t.co/SeIAEJK4OV
No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia https://t.co/grDLMNXuLT
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @JuanGrvas: En el seguimiento del cáncer de ovario, no emplee de rutina el CA-125 ni TAC. Mejor, seguimiento clínivo. https://t.co/NdvDR…
RT @JuanGrvas: En el seguimiento del cáncer de ovario, no emplee de rutina el CA-125 ni TAC. Mejor, seguimiento clínivo. https://t.co/NdvDR…
RT @JuanGrvas: Surveillance in Ovarian Cancer? Please, do not use CA-125 Tests and Computed Tomographic Scans @LessIsMoreMed https://t.co/…
RT @JuanGrvas: En el seguimiento del cáncer de ovario, no emplee de rutina el CA-125 ni TAC. Mejor, seguimiento clínivo. https://t.co/NdvDR…
RT @JuanGrvas: Surveillance in Ovarian Cancer? Please, do not use CA-125 Tests and Computed Tomographic Scans @LessIsMoreMed https://t.co/…
En el seguimiento del cáncer de ovario, no emplee de rutina el CA-125 ni TAC. Mejor, seguimiento clínivo. https://t.co/NdvDRE5wbW
Surveillance in Ovarian Cancer? Please, do not use CA-125 Tests and Computed Tomographic Scans @LessIsMoreMed https://t.co/NdvDRE5wbW
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
RT @sanoysalvoblog: No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia htt…
No existe el cribado del cáncer de ovario: Rx y "marcador tumoral" CA-125 sólo inducen gasto, angustia y iatrogenia https://t.co/fmMV2n358l